THOR MEDICAL ASA
Thor Medical | Alpha emitters for cancer therapy
Thor Medical will become the world leading supplier of alpha emitters for cancer therapy.
Keywords
researchdevelopment worknatural sciencesengineeringtechnologymedicineagricultureinterdisciplinary research
Links
Organization
- CEO
- JC
- Chairman of the board
- LS
Ludvik Sandnes1949
- Years since formation
- 15 years
- since Jul 7, 2009
- Type
- Public limited company
- VAT registered
- Yes
- Number of employees
- 8
Ownership
- Number of shares and share classes
- 233,539,006
- 1 share class
- Total number of shareholders
- 10874
- 589 companies, 10,285 persons
- Belongs to group of
Financials
- Annual total result 2023
- -2,855,000
- NOK
- Total equity 2023
- 274,629,000
- NOK
Last update: Nov 14, 2024
Management
Management / administration
Name | Role | Shares |
---|---|---|
JC | Managing Director/CEO | - |
Board
Name | Role | Shares |
---|---|---|
LS 1949 | Chairman | - |
JA 1967 | Board Member | - |
MK | Board Member | - |
Others
Name | Role | Shares |
---|---|---|
Auditor | - | |
Accountant | - |
Top 10 individual shareholders
Name | Role | Shares |
---|---|---|
TB | - | 19.96 % indirectly |
BG | - | 5.13 % indirectly |
CB | - | 2.82 % indirectly |
MB | - | 2.82 % indirectly |
JD | - | 2.66 % indirectly |
CR | - | 2.14 % indirectly |
CD | - | 1.85 % indirectly |
JM 1973 | - | 1.84 % directly |
AO 1959 | - | 1.23 % indirectly |
Last update: Aug 30, 2024
Ownership
Company shareholders
Name | Share class | Number of shares | Share |
---|---|---|---|
NO0010597883 | 64,000,942 | 27.4 % | |
NO0010597883 | 15,994,640 | 6.85 % | |
NO0010597883 | 14,663,147 | 6.28 % | |
NO0010597883 | 11,981,696 | 5.13 % | |
NO0010597883 | 10,532,567 | 4.51 % | |
JM 1973 | NO0010597883 | 4,300,000 | 1.84 % |
NO0010597883 | 3,165,920 | 1.36 % | |
NO0010597883 | 2,150,041 | 0.92 % | |
NO0010597883 | 2,000,000 | 0.86 % | |
NO0010597883 | 1,835,027 | 0.79 % | |
NO0010597883 | 1,792,445 | 0.77 % | |
NO0010597883 | 1,660,298 | 0.71 % | |
NO0010597883 | 1,584,324 | 0.68 % | |
NO0010597883 | 1,538,464 | 0.66 % | |
AF | NO0010597883 | 1,505,000 | 0.64 % |
NO0010597883 | 1,466,415 | 0.63 % | |
EK | NO0010597883 | 1,380,000 | 0.59 % |
NO0010597883 | 1,195,657 | 0.51 % | |
JP | NO0010597883 | 999,909 | 0.43 % |
NO0010597883 | 959,839 | 0.41 % | |
NO0010597883 | 845,071 | 0.36 % | |
TA 1959 | NO0010597883 | 813,355 | 0.35 % |
TK 1953 | NO0010597883 | 800,000 | 0.34 % |
NO0010597883 | 780,815 | 0.33 % | |
HR | NO0010597883 | 708,916 | 0.3 % |
NO0010597883 | 700,546 | 0.3 % | |
NO0010597883 | 700,000 | 0.3 % | |
GF 1955 | NO0010597883 | 700,000 | 0.3 % |
NO0010597883 | 650,000 | 0.28 % | |
NO0010597883 | 563,712 | 0.24 % | |
NO0010597883 | 541,247 | 0.23 % | |
SS | NO0010597883 | 534,147 | 0.23 % |
EW 1974 | NO0010597883 | 508,942 | 0.22 % |
NO0010597883 | 508,801 | 0.22 % | |
KØ | NO0010597883 | 500,000 | 0.21 % |
NO0010597883 | 500,000 | 0.21 % | |
DE 2003 | NO0010597883 | 497,719 | 0.21 % |
SN 1969 | NO0010597883 | 496,908 | 0.21 % |
NO0010597883 | 440,440 | 0.19 % | |
NO0010597883 | 429,500 | 0.18 % | |
NO0010597883 | 427,418 | 0.18 % | |
NO0010597883 | 426,081 | 0.18 % | |
AS 1966 | NO0010597883 | 400,100 | 0.17 % |
NO0010597883 | 400,000 | 0.17 % | |
NO0010597883 | 400,000 | 0.17 % | |
NO0010597883 | 390,000 | 0.17 % | |
NO0010597883 | 383,163 | 0.16 % | |
AS 1970 | NO0010597883 | 361,000 | 0.15 % |
SB | NO0010597883 | 360,000 | 0.15 % |
NO0010597883 | 350,364 | 0.15 % | |
KS 1970 | NO0010597883 | 348,991 | 0.15 % |
NO0010597883 | 344,996 | 0.15 % | |
NO0010597883 | 340,083 | 0.15 % | |
IG | NO0010597883 | 326,060 | 0.14 % |
NO0010597883 | 319,227 | 0.14 % | |
TD 1977 | NO0010597883 | 304,000 | 0.13 % |
MS 1959 | NO0010597883 | 300,000 | 0.13 % |
NO0010597883 | 299,998 | 0.13 % | |
SA 1965 | NO0010597883 | 295,900 | 0.13 % |
GH | NO0010597883 | 284,221 | 0.12 % |
LM 1966 | NO0010597883 | 281,932 | 0.12 % |
BS 1968 | NO0010597883 | 263,000 | 0.11 % |
HS | NO0010597883 | 260,100 | 0.11 % |
TS 1968 | NO0010597883 | 260,010 | 0.11 % |
MH | NO0010597883 | 257,604 | 0.11 % |
NO0010597883 | 251,000 | 0.11 % | |
TJ | NO0010597883 | 250,800 | 0.11 % |
TM 1971 | NO0010597883 | 248,600 | 0.11 % |
IH | NO0010597883 | 247,000 | 0.11 % |
NO0010597883 | 241,279 | 0.1 % | |
NO0010597883 | 240,000 | 0.1 % | |
NO0010597883 | 235,793 | 0.1 % | |
BA 1974 | NO0010597883 | 235,530 | 0.1 % |
TB | NO0010597883 | 234,781 | 0.1 % |
NO0010597883 | 234,667 | 0.1 % | |
SM | NO0010597883 | 229,740 | 0.1 % |
NO0010597883 | 228,072 | 0.1 % | |
EH 1986 | NO0010597883 | 226,079 | 0.1 % |
NO0010597883 | 224,554 | 0.1 % | |
MR | NO0010597883 | 210,000 | 0.09 % |
ZB | NO0010597883 | 205,390 | 0.09 % |
FS 1988 | NO0010597883 | 205,000 | 0.09 % |
NO0010597883 | 204,539 | 0.09 % | |
NO0010597883 | 204,120 | 0.09 % | |
PK | NO0010597883 | 200,666 | 0.09 % |
MD 1966 | NO0010597883 | 200,039 | 0.09 % |
DE 1957 | NO0010597883 | 200,000 | 0.09 % |
RE 1994 | NO0010597883 | 200,000 | 0.09 % |
NO0010597883 | 198,000 | 0.08 % | |
NO0010597883 | 196,759 | 0.08 % | |
NO0010597883 | 193,362 | 0.08 % | |
CK | NO0010597883 | 192,754 | 0.08 % |
NO0010597883 | 192,658 | 0.08 % | |
NO0010597883 | 190,148 | 0.08 % | |
AT | NO0010597883 | 188,236 | 0.08 % |
KG | NO0010597883 | 186,000 | 0.08 % |
OR | NO0010597883 | 175,000 | 0.07 % |
NO0010597883 | 171,172 | 0.07 % | |
RB 1962 | NO0010597883 | 170,800 | 0.07 % |
SI 1987 | NO0010597883 | 167,000 | 0.07 % |
Shares owned by the THOR MEDICAL ASA
Name | Share class | Number of shares | Share |
---|---|---|---|
Ordinary shares | 641,732 | 100 % |
Last update: May 24, 2024
Group structure
- Total operating income 2023: NOK 0Operating profit 2023: NOK -4,356,000Employees: 8
Financials
in NOK
Summary
Year | 2023 | 2022 | 2021 |
---|---|---|---|
Total operating income | 0 | 0 | 0 |
Annual Total Result | -2,855,000 | -310,251,000 | -433,151,000 |
Total assets | 278,406,000 | 95,301,000 | 281,528,000 |
Total liabilities | 3,777,000 | 42,079,000 | 151,189,000 |
Total equity | 274,629,000 | 53,222,000 | 130,339,000 |
P&L
Year | 2023 | 2022 | 2021 |
---|---|---|---|
Total operating income | 0 | 0 | 0 |
Total operating costs | 4,356,000 | 325,323,000 | 445,164,000 |
Operating result | -4,356,000 | -325,323,000 | -445,164,000 |
Financial income/costs | 1,501,000 | 15,179,000 | 12,149,000 |
Profit before tax | -2,855,000 | -310,144,000 | -433,015,000 |
Total tax & extraordinary income/cost | 0 | 107,000 | 136,000 |
Annual Total Result | -2,855,000 | -310,251,000 | -433,151,000 |
Balance overview
Year | 2023 | 2022 | 2021 |
---|---|---|---|
Total fixed assets | 234,728,000 | 674,000 | 6,080,000 |
Total current assets | 43,678,000 | 94,627,000 | 275,448,000 |
Total assets | 278,406,000 | 95,301,000 | 281,528,000 |
Short term debt | 3,777,000 | 42,079,000 | 151,189,000 |
Long term debt | 0 | 0 | 0 |
Total liabilities | 3,777,000 | 42,079,000 | 151,189,000 |
Contributed capital | 292,777,000 | 55,624,000 | 162,491,000 |
Retained earnings | -18,148,000 | -2,402,000 | -32,152,000 |
Total equity | 274,629,000 | 53,222,000 | 130,339,000 |
Total equity and liabilities | 278,406,000 | 95,301,000 | 281,528,000 |
Classification
Type of organization
Public limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.19
Industrial group
Other research and experimental development on natural sciences and engineering
72.190
Industrial group
Other research and experimental development on natural sciences and engineering